S. Loeb, M. Bjurlin, J. Nicholson, T. Tammela, D. Penson et al., Overdiagnosis and overtreatment of prostate cancer):104655. 5. HAS. Rapport d'évaluation technologique Destruction par ultrasons focalisés de haute intensité par voie rectale d'un adénocarcinome localisé de la prostate première prescription du psa chez l'homme asymptomatique, Dec 6. Assurance Maladie, Collège de Médecine Générale, 2010.

N. Mottet, Guidelines on Prostate-Cancer, 2016.

L. Salomon, Recommandations en onco-urologie 2013 du CCAFU : Cancer de la prostate, Progr??s en Urologie, vol.23, p.2013
DOI : 10.1016/S1166-7087(13)70048-4

K. Sennfält, P. Carlsson, J. Thorfinn, J. Frisk, M. Henriksson et al., Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population):22631. 12. HAS. Guide Méthodologique Choix méthodologiques pour l'évaluation économique à la HAS, Roberts M et al. Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2. Med Decis Making, pp.678-89, 2003.

J. Xu and A. Neale, Patient perspective on watchful waiting/active surveillance for localized prostate cancer):76370. 15. HAS. Guide ALD Cancer de la Prostate Prostate Cancer : diagnosis and treatment A taxonomy of model structures for economic evaluation of health technologies, J Am Board Fam Med JABFM. déc NICE. Clinical Guideline Health Econ. déc, vol.2515, issue.612, p.1295310, 2006.
DOI : 10.3122/jabfm.2012.06.120128

URL : http://www.jabfm.org/content/25/6/763.full.pdf

F. Hamdy, J. Donovan, J. Lane, M. Mason, C. Metcalfe et al., 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer, New England Journal of Medicine, vol.375, issue.15, p.141524, 2016.
DOI : 10.1056/NEJMoa1606220

M. Zelefsky, J. Eastham, A. Cronin, Z. Fuks, Z. Zhang et al., Metastasis After Radical Prostatectomy or External Beam Radiotherapy for Patients With Clinically Localized Prostate Cancer: A Comparison of Clinical Cohorts Adjusted for Case Mix, Journal of Clinical Oncology, vol.28, issue.9, p.150813, 2010.
DOI : 10.1200/JCO.2009.22.2265

R. Dersimonian and N. Laird, Meta-analysis in clinical trials, Controlled Clinical Trials, vol.7, issue.3, p.17788, 1986.
DOI : 10.1016/0197-2456(86)90046-2

. Arrêté-du, C. Castelli, E. Bauvin, X. Rebillard, M. Soulié et al., 165-1-1 du code de la sécurité sociale de la destruction par ultrasons focalisés de haute intensité par voie rectale d'un adénocarcinome localisé de la prostate | Legifrance Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data, Eur J Health Econ HEPAC Health Econ Prev Care. août, vol.12, issue.4, p.36371, 2011.

C. Ramsay, R. Pickard, C. Robertson, A. Close, L. Vale et al., Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer., Health Technology Assessment, vol.16, issue.41, p.1313, 2012.
DOI : 10.3310/hta16410

D. Naimark, N. Kabboul, and M. Krahn, The Half-Cycle Correction Revisited, Medical Decision Making, vol.29, issue.4, p.96170, 2013.
DOI : 10.1177/0272989X09340585

E. Fegoun, A. Barret, E. Prapotnich, D. Soon, S. Cathelineau et al., Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly: a feasibility study with 10 years follow-up, International braz j urol, vol.16, issue.101, pp.213-219, 2011.
DOI : 10.1111/j.1442-2042.2009.02389.x

R. Van-velthoven, F. Aoun, Q. Marcelis, S. Albisinni, M. Zanaty et al., A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer, Prostate Cancer and Prostatic Disease, vol.18, issue.1, p.7983, 2016.
DOI : 10.1155/2014/186782

P. Rischmann, A. Gelet, B. Riche, A. Villers, G. Pasticier et al., Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients, European Urology, vol.71, issue.2, p.26773, 2017.
DOI : 10.1016/j.eururo.2016.09.039

M. Bul, R. Van-den-bergh, X. Zhu, A. Rannikko, H. Vasarainen et al., Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer, BJU International, vol.29, issue.11, p.16727, 2012.
DOI : 10.1097/01.pas.0000173646.99337.b1

M. Bul, X. Zhu, R. Valdagni, T. Pickles, Y. Kakehi et al., Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study, European Urology, vol.63, issue.4, p.597603, 2013.
DOI : 10.1016/j.eururo.2012.11.005

S. Eggener, A. Mueller, R. Berglund, R. Ayyathurai, C. Soloway et al., A multi-institutional evaluation of active surveillance for low risk prostate cancer, J Urol. janv, vol.189, issue.1, pp.1925-1950, 2013.

J. Forde, P. Daly, S. White, M. Morrin, G. Smyth et al., A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland, Irish Journal of Medical Science (1971 -), vol.111, issue.7, p.37782, 2014.
DOI : 10.1111/j.1464-410X.2012.11641.x

R. Godtman, E. Holmberg, A. Khatami, J. Stranne, and J. Hugosson, Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial, Eur Urol. janv, vol.63, issue.1, p.1017, 2013.

V. Hernández, C. Blázquez, E. De-la-peña, E. Pérez-fernández, F. Díaz et al., Active surveillance in low-risk prostate cancer. Patient acceptance and results, Actas Urol??gicas Espa??olas (English Edition), vol.37, issue.9, p.5337, 2013.
DOI : 10.1016/j.acuroe.2013.02.005

L. Klotz, D. Vesprini, P. Sethukavalan, V. Jethava, L. Zhang et al., Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer, Journal of Clinical Oncology, vol.33, issue.3, p.2727, 2015.
DOI : 10.1200/JCO.2014.55.1192

S. Loeb, Y. Folkvaljon, D. Makarov, and O. Bratt, Five-year nationwide followup study of active surveillance for prostate cancer, Eur Urol. févr, vol.67, issue.2, p.2338, 2015.

R. Miocinovic, J. Jones, A. Pujara, E. Klein, and A. Stephenson, Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: improved outcomes with stringent enrollment criteria, Urology. avr, vol.77, issue.4, p.9804, 2011.

M. Preston, A. Feldman, J. Coen, W. Mcdougal, M. Smith et al., Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years, Urologic Oncology: Seminars and Original Investigations, vol.33, issue.9, pp.383-392, 2015.
DOI : 10.1016/j.urolonc.2015.04.015

M. Soloway, C. Soloway, A. Eldefrawy, K. Acosta, B. Kava et al., Careful Selection and Close Monitoring of Low-Risk Prostate Cancer Patients on Active Surveillance Minimizes the Need for Treatment, European Urology, vol.58, issue.6, p.8315, 2010.
DOI : 10.1016/j.eururo.2010.08.027

J. Thompson, A. Hayen, A. Landau, A. Haynes, A. Kalapara et al., Medium-term oncological outcomes for extended vs saturation biopsy and transrectal vs transperineal biopsy in active surveillance for prostate cancer, BJU International, vol.105, issue.Suppl. 2, p.88491, 2015.
DOI : 10.1111/j.1464-410X.2009.08938.x

J. Tosoian, M. Mamawala, J. Epstein, P. Landis, S. Wolf et al., Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer, Journal of Clinical Oncology, vol.33, issue.30, p.337985, 2015.
DOI : 10.1200/JCO.2015.62.5764

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863946/pdf

J. Tosoian, B. Trock, P. Landis, Z. Feng, J. Epstein et al., Active surveillance program for prostate cancer: an update of the Johns Hopkins experience Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial, J Clin Oncol Off J Am Soc Clin Oncol. 1 juin J Natl Cancer Inst, vol.29100, issue.4216, p.218590114454, 2008.

D. Chade, S. Shariat, A. Cronin, C. Savage, R. Karnes et al., Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multiinstitutional collaboration Tobacco use and outcome in radical prostatectomy patients, Eur Urol. août Cancer Med. avr, vol.606, issue.24, p.85764, 2011.

D. Dearnaley, G. Jovic, I. Syndikus, V. Khoo, R. Cowan et al., Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial, The Lancet Oncology, vol.15, issue.4, p.46473, 2014.
DOI : 10.1016/S1470-2045(14)70040-3

S. Freedland, V. Choeurng, L. Howard, D. Hoedt, A. Du-plessis et al., Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy, European Urology, vol.70, issue.4, p.58896, 2016.
DOI : 10.1016/j.eururo.2016.01.008

D. Makarov, E. Humphreys, L. Mangold, M. Carducci, A. Partin et al., The Natural History of Men Treated With Deferred Androgen Deprivation Therapy in Whom Metastatic Prostate Cancer Developed Following Radical Prostatectomy, The Journal of Urology, vol.179, issue.1, pp.156-161, 2008.
DOI : 10.1016/j.juro.2007.08.133

P. Paparel, A. Cronin, C. Savage, P. Scardino, and J. Eastham, Oncologic Outcome and Patterns of Recurrence after Salvage Radical Prostatectomy, European Urology, vol.55, issue.2, p.40410, 2009.
DOI : 10.1016/j.eururo.2008.07.007

G. Ploussard, M. Agamy, O. Alenda, Y. Allory, P. Mouracade et al., Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-na??ve patients, BJU International, vol.176, issue.3, p.174854, 2011.
DOI : 10.1016/j.juro.2006.06.017

R. Satkunasivam, G. Kulkarni, A. Zlotta, R. Kalnin, J. Trachtenberg et al., Pathological, Oncologic and Functional Outcomes of Radical Prostatectomy Following Active Surveillance, The Journal of Urology, vol.190, issue.1, p.915, 2013.
DOI : 10.1016/j.juro.2013.01.019

S. Taguchi, H. Fukuhara, and K. Shiraishi, Radical Prostatectomy versus External Beam Radiotherapy for cT1-4N0M0 Prostate Cancer: Comparison of Patient Outcomes Including Mortality Radical prostatectomy versus observation for localized prostate cancer, PloS One. N Engl J Med, vol.10367, issue.103, pp.141123-5320313, 2012.

Z. Zhigang, S. Wenlu, M. Peacock, J. Quirt, J. Morris et al., External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer. The Prostate. 1 mai Populationbased 10-year event-free survival after radical prostatectomy for patients with prostate cancer in British Columbia, Can Urol Assoc J, vol.679, issue.6, pp.65360-5540913, 1112.

M. Zelefsky, J. Eastham, A. Cronin, Z. Fuks, Z. Zhang et al., Metastasis After Radical Prostatectomy or External Beam Radiotherapy for Patients With Clinically Localized Prostate Cancer: A Comparison of Clinical Cohorts Adjusted for Case Mix, Journal of Clinical Oncology, vol.28, issue.9, p.150813, 2010.
DOI : 10.1200/JCO.2009.22.2265

C. Buron, L. Vu, B. Cosset, J. Pommier, P. Peiffert et al., Brachytherapy versus prostatectomy in localized prostate cancer: Results of a French multicenter prospective medico-economic study, International Journal of Radiation Oncology*Biology*Physics, vol.67, issue.3, p.81222, 2007.
DOI : 10.1016/j.ijrobp.2006.10.011

S. Stewart, L. Lenert, V. Bhatnagar, and R. Kaplan, Utilities for prostate cancer health states in men aged 60 and older, Med Care. avr, vol.43, issue.4, p.34755, 2005.

C. Bader, M. Donadel, A. Maillard, and A. Benard, A Method Based on the Remaining Value of Perfect Information for the Sample Size Calculation in Randomized Trial-Based Cost-Effectiveness Analyses, Value in Health, vol.18, issue.7, p.71920, 2015.
DOI : 10.1016/j.jval.2015.09.2725

. Subheading and . Or, diagnostic"[All Fields] AND "imaging"[All Fields]) OR "diagnostic imaging"[All Fields] OR "ultrasound"[All Fields] OR "ultrasonography"[MeSH Terms] OR "ultrasonography"[All Fields] OR "ultrasound"[All Fields] OR "ultrasonics"[MeSH Terms] OR "ultrasonics, OR (ablatherm[All Fields] OR ablathermie

. Article-de-rischmann, Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111

P. =. 111´2111´111´2, 53 = 281,2 personnes-année Extraction des incidences : -6 prostatectomies radicales (nPR) -3 radiothérapie (nRT) -2 décès